Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease

Marie K. Schluterman, Amanda E. Krysiak, Irfan S. Kathiriya, Nicola Abate, Manisha Chandalia, Deepak Srivastava, Vidu Garg

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Few known monogenic causes of non-syndromic congenital heart disease (CHD) have been identified. Mutations in NKX2.5 were initially implicated in familial cases of cardiac septal defects and subsequently, functionally significant NKX2.5 mutations were found in diverse forms of non-syndromic CHD. Similarly, mutations in GATA4, which encodes a cardiac transcription factor, were first identified in familial cases of cardiac septal defects. We hypothesize that individuals with non-syndromic CHD may harbor GATA4 mutations and that these mutations alter the biochemical properties of the protein. The coding region encompassing the six exons of GATA4 was screened in a study population of 157 patients with CHD. We identified several sequence variations in GATA4. We tested these novel sequence variations that altered evolutionarily conserved amino acids and other previously reported GATA4 mutations in various biochemical assays. The novel sequence variations had no biochemical deficits while a previously reported, but unstudied, missense mutation in GATA4 (S52F) functioned as a hypomorph in transactivation assays. We did not identify any novel GATA4 mutations in our patient population with non-syndromic CHD. Consistent with previous findings, GATA4 mutations that result in deficits in transactivation ability are consistently associated with CHD suggesting that normal transactivation properties of GATA4 are required for proper cardiac development.

Original languageEnglish (US)
Pages (from-to)817-825
Number of pages9
JournalAmerican Journal of Medical Genetics, Part A
Volume143
Issue number8
DOIs
StatePublished - Apr 15 2007
Externally publishedYes

Fingerprint

Sequence Analysis
Heart Diseases
Mutation
Heart Septal Defects
Transcriptional Activation
Missense Mutation
Population
Exons
Transcription Factors
Amino Acids
Proteins

Keywords

  • Cardiovascular malformations
  • Congenital heart defects
  • GATA4
  • Genetics
  • NKX2.5
  • Transcription factor

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Schluterman, M. K., Krysiak, A. E., Kathiriya, I. S., Abate, N., Chandalia, M., Srivastava, D., & Garg, V. (2007). Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. American Journal of Medical Genetics, Part A, 143(8), 817-825. https://doi.org/10.1002/ajmg.a.31652

Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. / Schluterman, Marie K.; Krysiak, Amanda E.; Kathiriya, Irfan S.; Abate, Nicola; Chandalia, Manisha; Srivastava, Deepak; Garg, Vidu.

In: American Journal of Medical Genetics, Part A, Vol. 143, No. 8, 15.04.2007, p. 817-825.

Research output: Contribution to journalArticle

Schluterman, MK, Krysiak, AE, Kathiriya, IS, Abate, N, Chandalia, M, Srivastava, D & Garg, V 2007, 'Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease', American Journal of Medical Genetics, Part A, vol. 143, no. 8, pp. 817-825. https://doi.org/10.1002/ajmg.a.31652
Schluterman, Marie K. ; Krysiak, Amanda E. ; Kathiriya, Irfan S. ; Abate, Nicola ; Chandalia, Manisha ; Srivastava, Deepak ; Garg, Vidu. / Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. In: American Journal of Medical Genetics, Part A. 2007 ; Vol. 143, No. 8. pp. 817-825.
@article{7d50e26b96e34c1ba2ec0274620ea86b,
title = "Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease",
abstract = "Few known monogenic causes of non-syndromic congenital heart disease (CHD) have been identified. Mutations in NKX2.5 were initially implicated in familial cases of cardiac septal defects and subsequently, functionally significant NKX2.5 mutations were found in diverse forms of non-syndromic CHD. Similarly, mutations in GATA4, which encodes a cardiac transcription factor, were first identified in familial cases of cardiac septal defects. We hypothesize that individuals with non-syndromic CHD may harbor GATA4 mutations and that these mutations alter the biochemical properties of the protein. The coding region encompassing the six exons of GATA4 was screened in a study population of 157 patients with CHD. We identified several sequence variations in GATA4. We tested these novel sequence variations that altered evolutionarily conserved amino acids and other previously reported GATA4 mutations in various biochemical assays. The novel sequence variations had no biochemical deficits while a previously reported, but unstudied, missense mutation in GATA4 (S52F) functioned as a hypomorph in transactivation assays. We did not identify any novel GATA4 mutations in our patient population with non-syndromic CHD. Consistent with previous findings, GATA4 mutations that result in deficits in transactivation ability are consistently associated with CHD suggesting that normal transactivation properties of GATA4 are required for proper cardiac development.",
keywords = "Cardiovascular malformations, Congenital heart defects, GATA4, Genetics, NKX2.5, Transcription factor",
author = "Schluterman, {Marie K.} and Krysiak, {Amanda E.} and Kathiriya, {Irfan S.} and Nicola Abate and Manisha Chandalia and Deepak Srivastava and Vidu Garg",
year = "2007",
month = "4",
day = "15",
doi = "10.1002/ajmg.a.31652",
language = "English (US)",
volume = "143",
pages = "817--825",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease

AU - Schluterman, Marie K.

AU - Krysiak, Amanda E.

AU - Kathiriya, Irfan S.

AU - Abate, Nicola

AU - Chandalia, Manisha

AU - Srivastava, Deepak

AU - Garg, Vidu

PY - 2007/4/15

Y1 - 2007/4/15

N2 - Few known monogenic causes of non-syndromic congenital heart disease (CHD) have been identified. Mutations in NKX2.5 were initially implicated in familial cases of cardiac septal defects and subsequently, functionally significant NKX2.5 mutations were found in diverse forms of non-syndromic CHD. Similarly, mutations in GATA4, which encodes a cardiac transcription factor, were first identified in familial cases of cardiac septal defects. We hypothesize that individuals with non-syndromic CHD may harbor GATA4 mutations and that these mutations alter the biochemical properties of the protein. The coding region encompassing the six exons of GATA4 was screened in a study population of 157 patients with CHD. We identified several sequence variations in GATA4. We tested these novel sequence variations that altered evolutionarily conserved amino acids and other previously reported GATA4 mutations in various biochemical assays. The novel sequence variations had no biochemical deficits while a previously reported, but unstudied, missense mutation in GATA4 (S52F) functioned as a hypomorph in transactivation assays. We did not identify any novel GATA4 mutations in our patient population with non-syndromic CHD. Consistent with previous findings, GATA4 mutations that result in deficits in transactivation ability are consistently associated with CHD suggesting that normal transactivation properties of GATA4 are required for proper cardiac development.

AB - Few known monogenic causes of non-syndromic congenital heart disease (CHD) have been identified. Mutations in NKX2.5 were initially implicated in familial cases of cardiac septal defects and subsequently, functionally significant NKX2.5 mutations were found in diverse forms of non-syndromic CHD. Similarly, mutations in GATA4, which encodes a cardiac transcription factor, were first identified in familial cases of cardiac septal defects. We hypothesize that individuals with non-syndromic CHD may harbor GATA4 mutations and that these mutations alter the biochemical properties of the protein. The coding region encompassing the six exons of GATA4 was screened in a study population of 157 patients with CHD. We identified several sequence variations in GATA4. We tested these novel sequence variations that altered evolutionarily conserved amino acids and other previously reported GATA4 mutations in various biochemical assays. The novel sequence variations had no biochemical deficits while a previously reported, but unstudied, missense mutation in GATA4 (S52F) functioned as a hypomorph in transactivation assays. We did not identify any novel GATA4 mutations in our patient population with non-syndromic CHD. Consistent with previous findings, GATA4 mutations that result in deficits in transactivation ability are consistently associated with CHD suggesting that normal transactivation properties of GATA4 are required for proper cardiac development.

KW - Cardiovascular malformations

KW - Congenital heart defects

KW - GATA4

KW - Genetics

KW - NKX2.5

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=34147136738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147136738&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.31652

DO - 10.1002/ajmg.a.31652

M3 - Article

C2 - 17352393

AN - SCOPUS:34147136738

VL - 143

SP - 817

EP - 825

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 8

ER -